Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials

Overview

Provider Statement

This continuing medical education activity is provided by

Support Statement

This activity is supported by independent medical education grants from AbbVie Inc.; Alcon Vision, LLC; Apellis Pharmaceuticals, Inc.; Bausch + Lomb; EyePoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Iveric Bio, Inc.; Regeneron Pharmaceuticals, Inc.; and Regenxbio, Inc.

Target Audience

The intended audience for this activity is retina fellows, ophthalmology residents, and other health care professionals involved in the management of patients with retinal disease.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Assess diagnostic modalities that can improve the early detection of retinal diseases.
• Examine evidence-based medicine, best practices, and treatment algorithms that can improve the medical management of retinal diseases.
• Recognize how data from key clinical trials can be applied to practice and improve the treatment of retinal vascular disorders.
• Evaluate new evidence regarding the use of multimodal therapeutic regimens in the treatment of retinal vascular disorders.
• Describe advances in imaging that can improve the diagnosis, treatment, and monitoring of retinal disorders.
• Examine evidence-based practices, procedures, and technology that improve the surgical management of retinal disorders.

Activity Chair

Rishi P. Singh, MD
Staff Physician and President
Cleveland Clinic Martin Hospitals
Stuart, FL
Professor of Ophthalmology, Lerner College of Medicine, Case Western Reserve University
Cleveland, OH

Faculty

Madhukar Kumar, BSE
Cole Eye Institute Bioinformatics Lab
Case Western Reserve University School of Medicine
Cleveland, OH

Christopher M. Maatouk, BA
Case Western Reserve University School of Medicine
Cleveland Clinic Center for Ophthalmic Bioinformatics
Cleveland, OH

Neha Sharma, BA
Medical Student/Research Fellow
Case Western Reserve University School of Medicine
Cleveland Clinic Cole Eye Institute
Cleveland, OH

Anna K. Wu, BS
Case Western Reserve University School of Medicine
Cleveland, OH

Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 30, 2022 to December 29, 2023.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 10 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Activity Chair and Faculty report the following relevant financial relationship(s)

Madhukar Kumar, BSE
No relevant financial relationships to disclose.

Christopher M. Maatouk, BA
No relevant financial relationships to disclose.

Neha Sharma, BA
No relevant financial relationships to disclose.

Rishi P. Singh, MD
Consultant: Alcon, Apellis, AsclepiX, Bausch + Lomb, Genentech, Gyroscope, Iveric, Novartis, Regeneron

Anna K. Wu, BS
No relevant financial relationships to disclose.

Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

“Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials” reviews clinical trials presented at the 2nd Annual Retina Summit for Fellows and Residents that took place on September 24, 2022.

Select clinical trial summaries presented at the retina summit for fellows and residents that took place on September 18, 2021, have been included within this activity and rereviewed by the above-mentioned faculty contributors for relevance and accuracy. 2021 planning committee and faculty contributors reported the following relevant financial relationships at the time of content development.

Jorge A. Fortun, MD
Consulting Fee: Alcon, Alimera, Allergan, Novartis, Zeiss
Contracted Research: Genentech, Novartis

Prithvi Mruthyunjaya, MD, MHS
Consulting Fee: Alcon, Aura Biosciences, Castle Biosciences

Rishi P. Singh, MD
Consulting Fee: Alcon, Apellis, Genentech, Gyroscope, Novartis, Regeneron, Zeiss
Contracted Research: Aerie, Apellis, Graybug Vision

Lediana Goduni, MD
Advisor: Alimera

Blanche Kuo, BS
No relevant financial relationships to disclose.

Kapil Mishra, MD
No relevant financial relationships to disclose.

Matthew Russell, BS
No relevant financial relationships to disclose.

Joshua Uhr, MD
Advisor: Alimera

Carolina C.S. Valentim, MD
No relevant financial relationships to disclose.

Anna Wu, BS
No relevant financial relationships to disclose.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. © 2022 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com